Hostname: page-component-7b7567c8c-z4zkx Total loading time: 0 Render date: 2026-11-17T10:37:30.346Z Has data issue: false hasContentIssue false

Phenotypic suppression by streptomycin-adenylate and bluensomycin-adenylate*

Published online by Cambridge University Press:  14 April 2009

J. H. Harwood
Affiliation:
Departments of Bacteriology and Immunology and Pediatrics, Harvard Medical School, and Children's Hospital Medical Center, Boston, Mass. 02115, U.S.A.
David H. Smith
Affiliation:
Departments of Bacteriology and Immunology and Pediatrics, Harvard Medical School, and Children's Hospital Medical Center, Boston, Mass. 02115, U.S.A.
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

An arg− conditionally Sm-dependent E. coli B strain became unable to grow on minimal agar containing low levels of Sm when the strain acquired an R factor which mediates Sm and Blu adenylation. The same R-containing strain, however, grew normally when Blu was substituted for Sm in the agar. The data strongly suggest that Sm-adenylate does not suppress the arg− phenotype in an in vivo system. The possibility that Blu-adenylate can cause phenotypic suppression without being bactericidal in vivo is discussed.

Information

Type
Research Article
Copyright
Copyright © Cambridge University Press 1969